-
1
-
-
2042437650
-
Initial sequencing and analysis of the human genome
-
Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, Funke R, Gage D, Harris K, Heaford A, Howland J, Kann L, Lehoczky J, LeVine R, McEwan P, McKernan K, Meldrim J, Mesirov JP, Miranda C, Morris W, Naylor J, Raymond C, Rosetti M, Santos R, Sheridan A, Sougnez C, Stange-Thomann N, et al: Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921
-
(2001)
Nature
, vol.409
, pp. 860-921
-
-
Lander, E.S.1
Linton, L.M.2
Birren, B.3
Nusbaum, C.4
Zody, M.C.5
Baldwin, J.6
Devon, K.7
Dewar, K.8
Doyle, M.9
FitzHugh, W.10
Funke, R.11
Gage, D.12
Harris, K.13
Heaford, A.14
Howland, J.15
Kann, L.16
Lehoczky, J.17
LeVine, R.18
McEwan, P.19
McKernan, K.20
Meldrim, J.21
Mesirov, J.P.22
Miranda, C.23
Morris, W.24
Naylor, J.25
Raymond, C.26
Rosetti, M.27
Santos, R.28
Sheridan, A.29
Sougnez, C.30
Stange-Thomann, N.31
more..
-
2
-
-
7444260846
-
The ENCODE (ENCyclopedia Of DNA Elements) Project
-
ENCODE Project Consortium: The ENCODE (ENCyclopedia Of DNA Elements) Project. Science 2004, 306:636-640
-
(2004)
Science
, vol.306
, pp. 636-640
-
-
-
3
-
-
84872847361
-
The genomic landscape of breast cancer as a therapeutic roadmap
-
Ellis MJ, Perou CM: The genomic landscape of breast cancer as a therapeutic roadmap. Cancer Discov 2013, 3:27-34
-
(2013)
Cancer Discov
, vol.3
, pp. 27-34
-
-
Ellis, M.J.1
Perou, C.M.2
-
4
-
-
79952532412
-
Cancer epigenetics: linking basic biology to clinical medicine
-
Tsai HC, Baylin SB: Cancer epigenetics: linking basic biology to clinical medicine. Cell Res 2011, 21:502-517
-
(2011)
Cell Res
, vol.21
, pp. 502-517
-
-
Tsai, H.C.1
Baylin, S.B.2
-
5
-
-
84862496309
-
Genome sequencing and cancer
-
Mardis ER: Genome sequencing and cancer. Curr Opin Genet Dev 2012, 22:245-250
-
(2012)
Curr Opin Genet Dev
, vol.22
, pp. 245-250
-
-
Mardis, E.R.1
-
6
-
-
84884826911
-
The next-generation sequencing revolution and its impact on genomics
-
Koboldt DC, Steinberg KM, Larson DE, Wilson RK, Mardis ER: The next-generation sequencing revolution and its impact on genomics. Cell 2013, 155:27-38
-
(2013)
Cell
, vol.155
, pp. 27-38
-
-
Koboldt, D.C.1
Steinberg, K.M.2
Larson, D.E.3
Wilson, R.K.4
Mardis, E.R.5
-
7
-
-
84872265962
-
Transcriptome analysis using next-generation sequencing
-
Mutz KO, Heilkenbrinker A, Lönne M, Walter JG, Stahl F: Transcriptome analysis using next-generation sequencing. Curr Opin Biotechnol 2013, 24:22-30
-
(2013)
Curr Opin Biotechnol
, vol.24
, pp. 22-30
-
-
Mutz, K.O.1
Heilkenbrinker, A.2
Lönne, M.3
Walter, J.G.4
Stahl, F.5
-
8
-
-
77951139631
-
Genome remodelling in a basal-like breast cancer metastasis and xenograft
-
Ding L, Ellis MJ, Li S, Larson DE, Chen K, Wallis JW, Harris CC, McLellan MD, Fulton RS, Fulton LL, Abbott RM, Hoog J, Dooling DJ, Koboldt DC, Schmidt H, Kalicki J, Zhang Q, Chen L, Lin L, Wendl MC, McMichael JF, Magrini VJ, Cook L, McGrath SD, Vickery TL, Appelbaum E, Deschryver K, Davies S, Guintoli T, Lin L, et al: Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 2010, 464:999-1005
-
(2010)
Nature
, vol.464
, pp. 999-1005
-
-
Ding, L.1
Ellis, M.J.2
Li, S.3
Larson, D.E.4
Chen, K.5
Wallis, J.W.6
Harris, C.C.7
McLellan, M.D.8
Fulton, R.S.9
Fulton, L.L.10
Abbott, R.M.11
Hoog, J.12
Dooling, D.J.13
Koboldt, D.C.14
Schmidt, H.15
Kalicki, J.16
Zhang, Q.17
Chen, L.18
Lin, L.19
Wendl, M.C.20
McMichael, J.F.21
Magrini, V.J.22
Cook, L.23
McGrath, S.D.24
Vickery, T.L.25
Appelbaum, E.26
Deschryver, K.27
Davies, S.28
Guintoli, T.29
Lin, L.30
more..
-
9
-
-
84875490185
-
Cancer genome landscapes
-
Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW: Cancer genome landscapes. Science 2013, 339:1546-1558
-
(2013)
Science
, vol.339
, pp. 1546-1558
-
-
Vogelstein, B.1
Papadopoulos, N.2
Velculescu, V.E.3
Zhou, S.4
Diaz, L.A.5
Kinzler, K.W.6
-
10
-
-
77957350610
-
Identification of driver and passenger DNA methylation in cancer by epigenomic analysis
-
Kalari S, Pfeifer GP: Identification of driver and passenger DNA methylation in cancer by epigenomic analysis. Adv Genet 2010, 70:277-308
-
(2010)
Adv Genet
, vol.70
, pp. 277-308
-
-
Kalari, S.1
Pfeifer, G.P.2
-
11
-
-
77249123407
-
Signatures of mutation and selection in the cancer genome
-
Bignell GR, Greenman CD, Davies H, Butler AP, Edkins S, Andrews JM, Buck G, Chen L, Beare D, Latimer C, Widaa S, Hinton J, Fahey C, Fu B, Swamy S, Dalgliesh GL, Teh BT, Deloukas P, Yang F, Campbell PJ, Futreal PA, Stratton MR: Signatures of mutation and selection in the cancer genome. Nature 2010, 463:893-898
-
(2010)
Nature
, vol.463
, pp. 893-898
-
-
Bignell, G.R.1
Greenman, C.D.2
Davies, H.3
Butler, A.P.4
Edkins, S.5
Andrews, J.M.6
Buck, G.7
Chen, L.8
Beare, D.9
Latimer, C.10
Widaa, S.11
Hinton, J.12
Fahey, C.13
Fu, B.14
Swamy, S.15
Dalgliesh, G.L.16
Teh, B.T.17
Deloukas, P.18
Yang, F.19
Campbell, P.J.20
Futreal, P.A.21
Stratton, M.R.22
more..
-
12
-
-
84884559238
-
Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts
-
Li S, Shen D, Shao J, Crowder R, Liu W, Prat A, He X, Liu S, Hoog J, Lu C, Ding L, Griffith OL, Miller C, Larson D, Fulton RS, Harrison M, Mooney T, McMichael JF, Luo J, Tao Y, Goncalves R, Schlosberg C, Hiken JF, Saied L, Sanchez C, Giuntoli T, Bumb C, Cooper C, Kitchens RT, Lin A, et al: Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts. Cell Rep 2013, 4:1116-1130
-
(2013)
Cell Rep
, vol.4
, pp. 1116-1130
-
-
Li, S.1
Shen, D.2
Shao, J.3
Crowder, R.4
Liu, W.5
Prat, A.6
He, X.7
Liu, S.8
Hoog, J.9
Lu, C.10
Ding, L.11
Griffith, O.L.12
Miller, C.13
Larson, D.14
Fulton, R.S.15
Harrison, M.16
Mooney, T.17
McMichael, J.F.18
Luo, J.19
Tao, Y.20
Goncalves, R.21
Schlosberg, C.22
Hiken, J.F.23
Saied, L.24
Sanchez, C.25
Giuntoli, T.26
Bumb, C.27
Cooper, C.28
Kitchens, R.T.29
Lin, A.30
more..
-
13
-
-
52949083552
-
Functional genomics of cancer
-
Liu ET: Functional genomics of cancer. Curr Opin Genet Dev 2008, 18:251-256
-
(2008)
Curr Opin Genet Dev
, vol.18
, pp. 251-256
-
-
Liu, E.T.1
-
14
-
-
84862584058
-
Whole-genome analysis informs breast cancer response to aromatase inhibition
-
Ellis MJ, Ding L, Shen D, Luo J, Suman VJ, Wallis JW, Van Tine BA, Hoog J, Goiffon RJ, Goldstein TC, Ng S, Lin L, Crowder R, Snider J, Ballman K, Weber J, Chen K, Koboldt DC, Kandoth C, Schierding WS, McMichael JF, Miller CA, Lu C, Harris CC, McLellan MD, Wendl MC, DeSchryver K, Allred DC, Esserman L, Unzeitig G, et al: Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature 2012, 486:353-360
-
(2012)
Nature
, vol.486
, pp. 353-360
-
-
Ellis, M.J.1
Ding, L.2
Shen, D.3
Luo, J.4
Suman, V.J.5
Wallis, J.W.6
Van Tine, B.A.7
Hoog, J.8
Goiffon, R.J.9
Goldstein, T.C.10
Ng, S.11
Lin, L.12
Crowder, R.13
Snider, J.14
Ballman, K.15
Weber, J.16
Chen, K.17
Koboldt, D.C.18
Kandoth, C.19
Schierding, W.S.20
McMichael, J.F.21
Miller, C.A.22
Lu, C.23
Harris, C.C.24
McLellan, M.D.25
Wendl, M.C.26
DeSchryver, K.27
Allred, D.C.28
Esserman, L.29
Unzeitig, G.30
more..
-
15
-
-
84892702777
-
Oestrogen increases haematopoietic stem-cell self-renewal in females and during pregnancy
-
Nakada D, Oguro H, Levi BP, Ryan N, Kitano A, Saitoh Y, Takeichi M, Wendt GR, Morrison SJ: Oestrogen increases haematopoietic stem-cell self-renewal in females and during pregnancy. Nature 2014, 505:555-558
-
(2014)
Nature
, vol.505
, pp. 555-558
-
-
Nakada, D.1
Oguro, H.2
Levi, B.P.3
Ryan, N.4
Kitano, A.5
Saitoh, Y.6
Takeichi, M.7
Wendt, G.R.8
Morrison, S.J.9
-
16
-
-
84877028141
-
Comprehensive molecular portraits of human breast tumours
-
Network CGA: Comprehensive molecular portraits of human breast tumours. Nature 2012, 490:61-70
-
(2012)
Nature
, vol.490
, pp. 61-70
-
-
Network, C.G.A.1
-
17
-
-
0017167185
-
The clonal evolution of tumor cell populations
-
Nowell PC: The clonal evolution of tumor cell populations. Science 1976, 194:23-28
-
(1976)
Science
, vol.194
, pp. 23-28
-
-
Nowell, P.C.1
-
18
-
-
78650959663
-
Massive genomic rearrangement acquired in a single catastrophic event during cancer development
-
Stephens PJ, Greenman CD, Fu B, Yang F, Bignell GR, Mudie LJ, Pleasance ED, Lau KW, Beare D, Stebbings LA, McLaren S, Lin ML, McBride DJ, Varela I, Nik-Zainal S, Leroy C, Jia M, Menzies A, Butler AP, Teague JW, Quail MA, Burton J, Swerdlow H, Carter NP, Morsberger LA, Iacobuzio-Donahue C, Follows GA, Green AR, Flanagan AM, Stratton MR, et al: Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 2011, 144:27-40
-
(2011)
Cell
, vol.144
, pp. 27-40
-
-
Stephens, P.J.1
Greenman, C.D.2
Fu, B.3
Yang, F.4
Bignell, G.R.5
Mudie, L.J.6
Pleasance, E.D.7
Lau, K.W.8
Beare, D.9
Stebbings, L.A.10
McLaren, S.11
Lin, M.L.12
McBride, D.J.13
Varela, I.14
Nik-Zainal, S.15
Leroy, C.16
Jia, M.17
Menzies, A.18
Butler, A.P.19
Teague, J.W.20
Quail, M.A.21
Burton, J.22
Swerdlow, H.23
Carter, N.P.24
Morsberger, L.A.25
Iacobuzio-Donahue, C.26
Follows, G.A.27
Green, A.R.28
Flanagan, A.M.29
Stratton, M.R.30
more..
-
19
-
-
84893000347
-
Chromothripsis-like patterns are recurring but heterogeneously distributed features in a survey of 22,347 cancer genome screens
-
Cai H, Kumar N, Bagheri HC, von Mering C, Robinson MD, Baudis M: Chromothripsis-like patterns are recurring but heterogeneously distributed features in a survey of 22,347 cancer genome screens. BMC Genomics 2014, 15:82
-
(2014)
BMC Genomics
, vol.15
, pp. 82
-
-
Cai, H.1
Kumar, N.2
Bagheri, H.C.3
von Mering, C.4
Robinson, M.D.5
Baudis, M.6
-
20
-
-
84861541343
-
Mutational processes molding the genomes of 21 breast cancers
-
Nik-Zainal S, Alexandrov LB, Wedge DC, Van Loo P, Greenman CD, Raine K, Jones D, Hinton J, Marshall J, Stebbings LA, Menzies A, Martin S, Leung K, Chen L, Leroy C, Ramakrishna M, Rance R, Lau KW, Mudie LJ, Varela I, McBride DJ, Bignell GR, Cooke SL, Shlien A, Gamble J, Whitmore I, Maddison M, Tarpey PS, Davies HR, Papaemmanuil E, et al: Mutational processes molding the genomes of 21 breast cancers. Cell 2012, 149:979-993
-
(2012)
Cell
, vol.149
, pp. 979-993
-
-
Nik-Zainal, S.1
Alexandrov, L.B.2
Wedge, D.C.3
Van Loo, P.4
Greenman, C.D.5
Raine, K.6
Jones, D.7
Hinton, J.8
Marshall, J.9
Stebbings, L.A.10
Menzies, A.11
Martin, S.12
Leung, K.13
Chen, L.14
Leroy, C.15
Ramakrishna, M.16
Rance, R.17
Lau, K.W.18
Mudie, L.J.19
Varela, I.20
McBride, D.J.21
Bignell, G.R.22
Cooke, S.L.23
Shlien, A.24
Gamble, J.25
Whitmore, I.26
Maddison, M.27
Tarpey, P.S.28
Davies, H.R.29
Papaemmanuil, E.30
more..
-
21
-
-
84883432724
-
An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers
-
Roberts SA, Lawrence MS, Klimczak LJ, Grimm SA, Fargo D, Stojanov P, Kiezun A, Kryukov GV, Carter SL, Saksena G, Harris S, Shah RR, Resnick MA, Getz G, Gordenin DA: An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat Genet 2013, 45:970-976
-
(2013)
Nat Genet
, vol.45
, pp. 970-976
-
-
Roberts, S.A.1
Lawrence, M.S.2
Klimczak, L.J.3
Grimm, S.A.4
Fargo, D.5
Stojanov, P.6
Kiezun, A.7
Kryukov, G.V.8
Carter, S.L.9
Saksena, G.10
Harris, S.11
Shah, R.R.12
Resnick, M.A.13
Getz, G.14
Gordenin, D.A.15
-
22
-
-
33947101019
-
Patterns of somatic mutation in human cancer genomes
-
Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C, Edkins S, O'Meara S, Vastrik I, Schmidt EE, Avis T, Barthorpe S, Bhamra G, Buck G, Choudhury B, Clements J, Cole J, Dicks E, Forbes S, Gray K, Halliday K, Harrison R, Hills K, Hinton J, Jenkinson A, Jones D, et al: Patterns of somatic mutation in human cancer genomes. Nature 2007, 446:153-158
-
(2007)
Nature
, vol.446
, pp. 153-158
-
-
Greenman, C.1
Stephens, P.2
Smith, R.3
Dalgliesh, G.L.4
Hunter, C.5
Bignell, G.6
Davies, H.7
Teague, J.8
Butler, A.9
Stevens, C.10
Edkins, S.11
O'Meara, S.12
Vastrik, I.13
Schmidt, E.E.14
Avis, T.15
Barthorpe, S.16
Bhamra, G.17
Buck, G.18
Choudhury, B.19
Clements, J.20
Cole, J.21
Dicks, E.22
Forbes, S.23
Gray, K.24
Halliday, K.25
Harrison, R.26
Hills, K.27
Hinton, J.28
Jenkinson, A.29
Jones, D.30
more..
-
23
-
-
79951821948
-
Poly(ADP-ribose) polymerase (PARP) inhibitors: exploiting a synthetic lethal strategy in the clinic
-
Yap TA, Sandhu SK, Carden CP, de Bono JS: Poly(ADP-ribose) polymerase (PARP) inhibitors: exploiting a synthetic lethal strategy in the clinic. CA Cancer J Clin 2011, 61:31-49
-
(2011)
CA Cancer J Clin
, vol.61
, pp. 31-49
-
-
Yap, T.A.1
Sandhu, S.K.2
Carden, C.P.3
de Bono, J.S.4
-
24
-
-
70349969478
-
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
-
Shah SP, Morin RD, Khattra J, Prentice L, Pugh T, Burleigh A, Delaney A, Gelmon K, Guliany R, Senz J, Steidl C, Holt RA, Jones S, Sun M, Leung G, Moore R, Severson T, Taylor GA, TeschendorffAE, Tse K, Turashvili G, Varhol R, Warren RL, Watson P, Zhao Y, Caldas C, Huntsman D, Hirst M, Marra MA, Aparicio S: Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 2009, 461:809-813
-
(2009)
Nature
, vol.461
, pp. 809-813
-
-
Shah, S.P.1
Morin, R.D.2
Khattra, J.3
Prentice, L.4
Pugh, T.5
Burleigh, A.6
Delaney, A.7
Gelmon, K.8
Guliany, R.9
Senz, J.10
Steidl, C.11
Holt, R.A.12
Jones, S.13
Sun, M.14
Leung, G.15
Moore, R.16
Severson, T.17
Taylor, G.A.18
Teschendorff, A.E.19
Tse, K.20
Turashvili, G.21
Varhol, R.22
Warren, R.L.23
Watson, P.24
Zhao, Y.25
Caldas, C.26
Huntsman, D.27
Hirst, M.28
Marra, M.A.29
Aparicio, S.30
more..
-
25
-
-
0031979655
-
Aneuploidy of chromosome 8 as detected by interphase fluorescence in situ hybridization is a recurrent finding in primary and metastatic breast cancer
-
Roka S, Fiegl M, Zojer N, Filipits M, Schuster R, Steiner B, Jakesz R, Huber H, Drach J: Aneuploidy of chromosome 8 as detected by interphase fluorescence in situ hybridization is a recurrent finding in primary and metastatic breast cancer. Breast Cancer Res Treat 1998, 48:125-133
-
(1998)
Breast Cancer Res Treat
, vol.48
, pp. 125-133
-
-
Roka, S.1
Fiegl, M.2
Zojer, N.3
Filipits, M.4
Schuster, R.5
Steiner, B.6
Jakesz, R.7
Huber, H.8
Drach, J.9
-
26
-
-
76049114936
-
Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer
-
Park SY, Lee HE, Li H, Shipitsin M, Gelman R, Polyak K: Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer. Clin Cancer Res 2010, 16:876-887
-
(2010)
Clin Cancer Res
, vol.16
, pp. 876-887
-
-
Park, S.Y.1
Lee, H.E.2
Li, H.3
Shipitsin, M.4
Gelman, R.5
Polyak, K.6
-
27
-
-
0035864901
-
Clone heterogeneity in diploid and aneuploid breast carcinomas as detected by FISH
-
Farabegoli F, Santini D, Ceccarelli C, Taffurelli M, Marrano D, Baldini N: Clone heterogeneity in diploid and aneuploid breast carcinomas as detected by FISH. Cytometry 2001, 46:50-56
-
(2001)
Cytometry
, vol.46
, pp. 50-56
-
-
Farabegoli, F.1
Santini, D.2
Ceccarelli, C.3
Taffurelli, M.4
Marrano, D.5
Baldini, N.6
-
28
-
-
0030020692
-
Karyotypic comparisons of multiple tumorous and macroscopically normal surrounding tissue samples from patients with breast cancer
-
Teixeira MR, Pandis N, Bardi G, Andersen JA, Heim S: Karyotypic comparisons of multiple tumorous and macroscopically normal surrounding tissue samples from patients with breast cancer. Cancer Res 1996, 56:855-859
-
(1996)
Cancer Res
, vol.56
, pp. 855-859
-
-
Teixeira, M.R.1
Pandis, N.2
Bardi, G.3
Andersen, J.A.4
Heim, S.5
-
29
-
-
0028848437
-
Clonal heterogeneity in breast cancer: karyotypic comparisons of multiple intraand extra-tumorous samples from 3 patients
-
Teixeira MR, Pandis N, Bardi G, Andersen JA, Mitelman F, Heim S: Clonal heterogeneity in breast cancer: karyotypic comparisons of multiple intraand extra-tumorous samples from 3 patients. Int J Cancer 1995, 63:63-68
-
(1995)
Int J Cancer
, vol.63
, pp. 63-68
-
-
Teixeira, M.R.1
Pandis, N.2
Bardi, G.3
Andersen, J.A.4
Mitelman, F.5
Heim, S.6
-
30
-
-
84863393080
-
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing
-
Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, Martinez P, Matthews N, Stewart A, Tarpey P, Varela I, Phillimore B, Begum S, McDonald NQ, Butler A, Jones D, Raine K, Latimer C, Santos CR, Nohadani M, Eklund AC, Spencer-Dene B, Clark G, Pickering L, Stamp G, Gore M, Szallasi Z, Downward J, Futreal PA, Swanton C: Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012, 366:883-892
-
(2012)
N Engl J Med
, vol.366
, pp. 883-892
-
-
Gerlinger, M.1
Rowan, A.J.2
Horswell, S.3
Larkin, J.4
Endesfelder, D.5
Gronroos, E.6
Martinez, P.7
Matthews, N.8
Stewart, A.9
Tarpey, P.10
Varela, I.11
Phillimore, B.12
Begum, S.13
McDonald, N.Q.14
Butler, A.15
Jones, D.16
Raine, K.17
Latimer, C.18
Santos, C.R.19
Nohadani, M.20
Eklund, A.C.21
Spencer-Dene, B.22
Clark, G.23
Pickering, L.24
Stamp, G.25
Gore, M.26
Szallasi, Z.27
Downward, J.28
Futreal, P.A.29
Swanton, C.30
more..
-
31
-
-
79953766940
-
Tumour evolution inferred by single-cell sequencing
-
Navin N, Kendall J, Troge J, Andrews P, Rodgers L, McIndoo J, Cook K, Stepansky A, Levy D, Esposito D, Muthuswamy L, Krasnitz A, McCombie WR, Hicks J, Wigler M: Tumour evolution inferred by single-cell sequencing. Nature 2011, 472:90-94
-
(2011)
Nature
, vol.472
, pp. 90-94
-
-
Navin, N.1
Kendall, J.2
Troge, J.3
Andrews, P.4
Rodgers, L.5
McIndoo, J.6
Cook, K.7
Stepansky, A.8
Levy, D.9
Esposito, D.10
Muthuswamy, L.11
Krasnitz, A.12
McCombie, W.R.13
Hicks, J.14
Wigler, M.15
-
32
-
-
82655184653
-
Personalized oncology through integrative high-throughput sequencing: a pilot study
-
Roychowdhury S, Iyer MK, Robinson DR, Lonigro RJ, Wu YM, Cao X, Kalyana-Sundaram S, Sam L, Balbin OA, Quist MJ, Barrette T, Everett J, Siddiqui J, Kunju LP, Navone N, Araujo JC, Troncoso P, Logothetis CJ, Innis JW, Smith DC, Lao CD, Kim SY, Roberts JS, Gruber SB, Pienta KJ, Talpaz M, Chinnaiyan AM: Personalized oncology through integrative high-throughput sequencing: a pilot study. Sci Transl Med 2011, 3:111ra121
-
(2011)
Sci Transl Med
, vol.3
-
-
Roychowdhury, S.1
Iyer, M.K.2
Robinson, D.R.3
Lonigro, R.J.4
Wu, Y.M.5
Cao, X.6
Kalyana-Sundaram, S.7
Sam, L.8
Balbin, O.A.9
Quist, M.J.10
Barrette, T.11
Everett, J.12
Siddiqui, J.13
Kunju, L.P.14
Navone, N.15
Araujo, J.C.16
Troncoso, P.17
Logothetis, C.J.18
Innis, J.W.19
Smith, D.C.20
Lao, C.D.21
Kim, S.Y.22
Roberts, J.S.23
Gruber, S.B.24
Pienta, K.J.25
Talpaz, M.26
Chinnaiyan, A.M.27
more..
-
33
-
-
84877278637
-
Implementing personalized cancer genomics in clinical trials
-
Simon R, Roychowdhury S: Implementing personalized cancer genomics in clinical trials. Nat Rev Drug Discov 2013, 12:358-369
-
(2013)
Nat Rev Drug Discov
, vol.12
, pp. 358-369
-
-
Simon, R.1
Roychowdhury, S.2
-
34
-
-
84879086143
-
From integrative genomics to therapeutic targets
-
Natrajan R, Wilkerson P: From integrative genomics to therapeutic targets. Cancer Res 2013, 73:3483-3488
-
(2013)
Cancer Res
, vol.73
, pp. 3483-3488
-
-
Natrajan, R.1
Wilkerson, P.2
-
35
-
-
84879508865
-
Prioritizing potentially druggable mutations with dGene: an annotation tool for cancer genome sequencing data
-
Kumar RD, Chang LW, Ellis MJ, Bose R: Prioritizing potentially druggable mutations with dGene: an annotation tool for cancer genome sequencing data. PLoS One 2013, 8:e67980
-
(2013)
PLoS One
, vol.8
-
-
Kumar, R.D.1
Chang, L.W.2
Ellis, M.J.3
Bose, R.4
-
36
-
-
84888862866
-
DGIdb: mining the druggable genome
-
Griffith M, Griffith OL, Coffman AC, Weible JV, McMichael JF, Spies NC, Koval J, Das I, Callaway MB, Eldred JM, Miller CA, Subramanian J, Govindan R, Kumar RD, Bose R, Ding L, Walker JR, Larson DE, Dooling DJ, Smith SM, Ley TJ, Mardis ER, Wilson RK: DGIdb: mining the druggable genome. Nat Methods 2013, 10:1209-1210
-
(2013)
Nat Methods
, vol.10
, pp. 1209-1210
-
-
Griffith, M.1
Griffith, O.L.2
Coffman, A.C.3
Weible, J.V.4
McMichael, J.F.5
Spies, N.C.6
Koval, J.7
Das, I.8
Callaway, M.B.9
Eldred, J.M.10
Miller, C.A.11
Subramanian, J.12
Govindan, R.13
Kumar, R.D.14
Bose, R.15
Ding, L.16
Walker, J.R.17
Larson, D.E.18
Dooling, D.J.19
Smith, S.M.20
Ley, T.J.21
Mardis, E.R.22
Wilson, R.K.23
more..
-
38
-
-
84862523863
-
Sequence analysis of mutations and translocations across breast cancer subtypes
-
Banerji S, Cibulskis K, Rangel-Escareno C, Brown KK, Carter SL, Frederick AM, Lawrence MS, Sivachenko AY, Sougnez C, Zou L, Cortes ML, Fernandez-Lopez JC, Peng S, Ardlie KG, Auclair D, Bautista-Piña V, Duke F, Francis J, Jung J, Maffuz-Aziz A, Onofrio RC, Parkin M, Pho NH, Quintanar-Jurado V, Ramos AH, Rebollar-Vega R, Rodriguez-Cuevas S, Romero-Cordoba SL, Schumacher SE, Stransky N, et al: Sequence analysis of mutations and translocations across breast cancer subtypes. Nature 2012, 486:405-409
-
(2012)
Nature
, vol.486
, pp. 405-409
-
-
Banerji, S.1
Cibulskis, K.2
Rangel-Escareno, C.3
Brown, K.K.4
Carter, S.L.5
Frederick, A.M.6
Lawrence, M.S.7
Sivachenko, A.Y.8
Sougnez, C.9
Zou, L.10
Cortes, M.L.11
Fernandez-Lopez, J.C.12
Peng, S.13
Ardlie, K.G.14
Auclair, D.15
Bautista-Piña, V.16
Duke, F.17
Francis, J.18
Jung, J.19
Maffuz-Aziz, A.20
Onofrio, R.C.21
Parkin, M.22
Pho, N.H.23
Quintanar-Jurado, V.24
Ramos, A.H.25
Rebollar-Vega, R.26
Rodriguez-Cuevas, S.27
Romero-Cordoba, S.L.28
Schumacher, S.E.29
Stransky, N.30
more..
-
39
-
-
77955660663
-
Diverse somatic mutation patterns and pathway alterations in human cancers
-
Kan Z, Jaiswal BS, Stinson J, Janakiraman V, Bhatt D, Stern HM, Yue P, Haverty PM, Bourgon R, Zheng J, Moorhead M, Chaudhuri S, Tomsho LP, Peters BA, Pujara K, Cordes S, Davis DP, Carlton VE, Yuan W, Li L, Wang W, Eigenbrot C, Kaminker JS, Eberhard DA, Waring P, Schuster SC, Modrusan Z, Zhang Z, Stokoe D, de Sauvage FJ, et al: Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 2010, 466:869-873
-
(2010)
Nature
, vol.466
, pp. 869-873
-
-
Kan, Z.1
Jaiswal, B.S.2
Stinson, J.3
Janakiraman, V.4
Bhatt, D.5
Stern, H.M.6
Yue, P.7
Haverty, P.M.8
Bourgon, R.9
Zheng, J.10
Moorhead, M.11
Chaudhuri, S.12
Tomsho, L.P.13
Peters, B.A.14
Pujara, K.15
Cordes, S.16
Davis, D.P.17
Carlton, V.E.18
Yuan, W.19
Li, L.20
Wang, W.21
Eigenbrot, C.22
Kaminker, J.S.23
Eberhard, D.A.24
Waring, P.25
Schuster, S.C.26
Modrusan, Z.27
Zhang, Z.28
Stokoe, D.29
de Sauvage, F.J.30
more..
-
40
-
-
84862526929
-
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
-
Shah SP, Roth A, Goya R, Oloumi A, Ha G, Zhao Y, Turashvili G, Ding J, Tse K, Haffari G, Bashashati A, Prentice LM, Khattra J, Burleigh A, Yap D, Bernard V, McPherson A, Shumansky K, Crisan A, Giuliany R, Heravi-Moussavi A, Rosner J, Lai D, Birol I, Varhol R, Tam A, Dhalla N, Zeng T, Ma K, Chan SK, et al: The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 2012, 486:395-399
-
(2012)
Nature
, vol.486
, pp. 395-399
-
-
Shah, S.P.1
Roth, A.2
Goya, R.3
Oloumi, A.4
Ha, G.5
Zhao, Y.6
Turashvili, G.7
Ding, J.8
Tse, K.9
Haffari, G.10
Bashashati, A.11
Prentice, L.M.12
Khattra, J.13
Burleigh, A.14
Yap, D.15
Bernard, V.16
McPherson, A.17
Shumansky, K.18
Crisan, A.19
Giuliany, R.20
Heravi-Moussavi, A.21
Rosner, J.22
Lai, D.23
Birol, I.24
Varhol, R.25
Tam, A.26
Dhalla, N.27
Zeng, T.28
Ma, K.29
Chan, S.K.30
more..
-
41
-
-
84861576201
-
The landscape of cancer genes and mutational processes in breast cancer
-
Stephens PJ, Tarpey PS, Davies H, Van Loo P, Greenman C, Wedge DC, Nik-Zainal S, Martin S, Varela I, Bignell GR, Yates LR, Papaemmanuil E, Beare D, Butler A, Cheverton A, Gamble J, Hinton J, Jia M, Jayakumar A, Jones D, Latimer C, Lau KW, McLaren S, McBride DJ, Menzies A, Mudie L, Raine K, Rad R, Chapman MS, Teague J, et al: The landscape of cancer genes and mutational processes in breast cancer. Nature 2012, 486:400-404
-
(2012)
Nature
, vol.486
, pp. 400-404
-
-
Stephens, P.J.1
Tarpey, P.S.2
Davies, H.3
Van Loo, P.4
Greenman, C.5
Wedge, D.C.6
Nik-Zainal, S.7
Martin, S.8
Varela, I.9
Bignell, G.R.10
Yates, L.R.11
Papaemmanuil, E.12
Beare, D.13
Butler, A.14
Cheverton, A.15
Gamble, J.16
Hinton, J.17
Jia, M.18
Jayakumar, A.19
Jones, D.20
Latimer, C.21
Lau, K.W.22
McLaren, S.23
McBride, D.J.24
Menzies, A.25
Mudie, L.26
Raine, K.27
Rad, R.28
Chapman, M.S.29
Teague, J.30
more..
-
42
-
-
31544449750
-
Somatic mutations of ERBB2 kinase domain in gastric, colorectal, and breast carcinomas
-
Lee JW, Soung YH, Seo SH, Kim SY, Park CH, Wang YP, Park K, Nam SW, Park WS, Kim SH, Lee JY, Yoo NJ, Lee SH: Somatic mutations of ERBB2 kinase domain in gastric, colorectal, and breast carcinomas. Clin Cancer Res 2006, 12:57-61
-
(2006)
Clin Cancer Res
, vol.12
, pp. 57-61
-
-
Lee, J.W.1
Soung, Y.H.2
Seo, S.H.3
Kim, S.Y.4
Park, C.H.5
Wang, Y.P.6
Park, K.7
Nam, S.W.8
Park, W.S.9
Kim, S.H.10
Lee, J.Y.11
Yoo, N.J.12
Lee, S.H.13
-
43
-
-
84873918443
-
Activating HER2 mutations in HER2 gene amplification negative breast cancer
-
Bose R, Kavuri SM, Searleman AC, Shen W, Shen D, Koboldt DC, Monsey J, Goel N, Aronson AB, Li S, Ma CX, Ding L, Mardis ER, Ellis MJ: Activating HER2 mutations in HER2 gene amplification negative breast cancer. Cancer Discov 2013, 3:224-237
-
(2013)
Cancer Discov
, vol.3
, pp. 224-237
-
-
Bose, R.1
Kavuri, S.M.2
Searleman, A.C.3
Shen, W.4
Shen, D.5
Koboldt, D.C.6
Monsey, J.7
Goel, N.8
Aronson, A.B.9
Li, S.10
Ma, C.X.11
Ding, L.12
Mardis, E.R.13
Ellis, M.J.14
-
44
-
-
84888391516
-
ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
-
Toy W, Shen Y, Won H, Green B, Sakr RA, Will M, Li Z, Gala K, Fanning S, King TA, Hudis C, Chen D, Taran T, Hortobagyi G, Greene G, Berger M, Baselga J, Chandarlapaty S: ESR1 ligand-binding domain mutations in hormone-resistant breast cancer. Nat Genet 2013, 45:1439-1445
-
(2013)
Nat Genet
, vol.45
, pp. 1439-1445
-
-
Toy, W.1
Shen, Y.2
Won, H.3
Green, B.4
Sakr, R.A.5
Will, M.6
Li, Z.7
Gala, K.8
Fanning, S.9
King, T.A.10
Hudis, C.11
Chen, D.12
Taran, T.13
Hortobagyi, G.14
Greene, G.15
Berger, M.16
Baselga, J.17
Chandarlapaty, S.18
-
45
-
-
84888381937
-
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
-
Robinson DR, Wu YM, Vats P, Su F, Lonigro RJ, Cao X, Kalyana-Sundaram S, Wang R, Ning Y, Hodges L, Gursky A, Siddiqui J, Tomlins SA, Roychowdhury S, Pienta KJ, Kim SY, Roberts JS, Rae JM, Van Poznak CH, Hayes DF, Chugh R, Kunju LP, Talpaz M, Schott AF, Chinnaiyan AM: Activating ESR1 mutations in hormone-resistant metastatic breast cancer. Nat Genet 2013, 45:1446-1451
-
(2013)
Nat Genet
, vol.45
, pp. 1446-1451
-
-
Robinson, D.R.1
Wu, Y.M.2
Vats, P.3
Su, F.4
Lonigro, R.J.5
Cao, X.6
Kalyana-Sundaram, S.7
Wang, R.8
Ning, Y.9
Hodges, L.10
Gursky, A.11
Siddiqui, J.12
Tomlins, S.A.13
Roychowdhury, S.14
Pienta, K.J.15
Kim, S.Y.16
Roberts, J.S.17
Rae, J.M.18
Van Poznak, C.H.19
Hayes, D.F.20
Chugh, R.21
Kunju, L.P.22
Talpaz, M.23
Schott, A.F.24
Chinnaiyan, A.M.25
more..
-
46
-
-
77956445286
-
Finding the tumor copycat. Therapy fails, patients don't
-
Ellis LM, Fidler IJ: Finding the tumor copycat. Therapy fails, patients don't. Nat Med 2010, 16:974-975
-
(2010)
Nat Med
, vol.16
, pp. 974-975
-
-
Ellis, L.M.1
Fidler, I.J.2
-
47
-
-
2042458747
-
Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials
-
Johnson JI, Decker S, Zaharevitz D, Rubinstein LV, Venditti JM, Schepartz S, Kalyandrug S, Christian M, Arbuck S, Hollingshead M, Sausville EA: Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials. Br J Cancer 2001, 84:1424-1431
-
(2001)
Br J Cancer
, vol.84
, pp. 1424-1431
-
-
Johnson, J.I.1
Decker, S.2
Zaharevitz, D.3
Rubinstein, L.V.4
Venditti, J.M.5
Schepartz, S.6
Kalyandrug, S.7
Christian, M.8
Arbuck, S.9
Hollingshead, M.10
Sausville, E.A.11
-
48
-
-
0141566685
-
Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models
-
Voskoglou-Nomikos T, Pater JL, Seymour L: Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models. Clin Cancer Res 2003, 9:4227-4239
-
(2003)
Clin Cancer Res
, vol.9
, pp. 4227-4239
-
-
Voskoglou-Nomikos, T.1
Pater, J.L.2
Seymour, L.3
-
49
-
-
77956021862
-
Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic review
-
Jin K, Teng L, Shen Y, He K, Xu Z, Li G: Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic review. Clin Transl Oncol 2010, 12:473-480
-
(2010)
Clin Transl Oncol
, vol.12
, pp. 473-480
-
-
Jin, K.1
Teng, L.2
Shen, Y.3
He, K.4
Xu, Z.5
Li, G.6
-
50
-
-
34347254640
-
Establishment of human tumor xenografts in immunodeficient mice
-
Morton CL, Houghton PJ: Establishment of human tumor xenografts in immunodeficient mice. Nat Protoc 2007, 2:247-250
-
(2007)
Nat Protoc
, vol.2
, pp. 247-250
-
-
Morton, C.L.1
Houghton, P.J.2
-
51
-
-
58549118535
-
Direct in vivo xenograft tumor model for predicting chemotherapeutic drug response in cancer patients
-
Rubio-Viqueira B, Hidalgo M: Direct in vivo xenograft tumor model for predicting chemotherapeutic drug response in cancer patients. Clin Pharmacol Ther 2009, 85:217-221
-
(2009)
Clin Pharmacol Ther
, vol.85
, pp. 217-221
-
-
Rubio-Viqueira, B.1
Hidalgo, M.2
-
52
-
-
33645734205
-
Contributions of human tumor xenografts to anticancer drug development
-
discussion 3354
-
Sausville EA, Burger AM: Contributions of human tumor xenografts to anticancer drug development. Cancer Res 2006, 66:3351-3354. discussion 3354
-
(2006)
Cancer Res
, vol.66
, pp. 3351-3354
-
-
Sausville, E.A.1
Burger, A.M.2
-
53
-
-
81255135837
-
Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes
-
DeRose YS, Wang G, Lin YC, Bernard PS, Buys SS, Ebbert MT, Factor R, Matsen C, Milash BA, Nelson E, Neumayer L, Randall RL, Stijleman IJ, Welm BE, Welm AL: Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. Nat Med 2011, 17:1514-1520
-
(2011)
Nat Med
, vol.17
, pp. 1514-1520
-
-
DeRose, Y.S.1
Wang, G.2
Lin, Y.C.3
Bernard, P.S.4
Buys, S.S.5
Ebbert, M.T.6
Factor, R.7
Matsen, C.8
Milash, B.A.9
Nelson, E.10
Neumayer, L.11
Randall, R.L.12
Stijleman, I.J.13
Welm, B.E.14
Welm, A.L.15
-
54
-
-
84865187027
-
Analysis of MDM2 and MDM4 single nucleotide polymorphisms, mRNA splicing and protein expression in retinoblastoma
-
McEvoy J, Ulyanov A, Brennan R, Wu G, Pounds S, Zhang J, Dyer MA: Analysis of MDM2 and MDM4 single nucleotide polymorphisms, mRNA splicing and protein expression in retinoblastoma. PLoS One 2012, 7:e42739
-
(2012)
PLoS One
, vol.7
-
-
McEvoy, J.1
Ulyanov, A.2
Brennan, R.3
Wu, G.4
Pounds, S.5
Zhang, J.6
Dyer, M.A.7
-
55
-
-
84855784479
-
Molecular profiling of patient-derived breast cancer xenografts
-
Reyal F, Guyader C, Decraene C, Lucchesi C, Auger N, Assayag F, De Plater L, Gentien D, Poupon MF, Cottu P, De Cremoux P, Gestraud P, Vincent-Salomon A, Fontaine JJ, Roman-Roman S, Delattre O, Decaudin D, Marangoni E: Molecular profiling of patient-derived breast cancer xenografts. Breast Cancer Res 2012, 14:R11
-
(2012)
Breast Cancer Res
, vol.14
, pp. R11
-
-
Reyal, F.1
Guyader, C.2
Decraene, C.3
Lucchesi, C.4
Auger, N.5
Assayag, F.6
De Plater, L.7
Gentien, D.8
Poupon, M.F.9
Cottu, P.10
De Cremoux, P.11
Gestraud, P.12
Vincent-Salomon, A.13
Fontaine, J.J.14
Roman-Roman, S.15
Delattre, O.16
Decaudin, D.17
Marangoni, E.18
-
56
-
-
84860378325
-
Global gene expression profiling confirms the molecular fidelity of primary tumor-based orthotopic xenograft mouse models of medulloblastoma
-
Zhao X, Liu Z, Yu L, Zhang Y, Baxter P, Voicu H, Gurusiddappa S, Luan J, Su JM, Leung HC, Li XN: Global gene expression profiling confirms the molecular fidelity of primary tumor-based orthotopic xenograft mouse models of medulloblastoma. Neuro Oncol 2012, 14:574-583
-
(2012)
Neuro Oncol
, vol.14
, pp. 574-583
-
-
Zhao, X.1
Liu, Z.2
Yu, L.3
Zhang, Y.4
Baxter, P.5
Voicu, H.6
Gurusiddappa, S.7
Luan, J.8
Su, J.M.9
Leung, H.C.10
Li, X.N.11
-
57
-
-
84866436691
-
PARADIGM-SHIFT predicts the function of mutations in multiple cancers using pathway impact analysis
-
Ng S, Collisson EA, Sokolov A, Goldstein T, Gonzalez-Perez A, Lopez-Bigas N, Benz C, Haussler D, Stuart JM: PARADIGM-SHIFT predicts the function of mutations in multiple cancers using pathway impact analysis. Bioinformatics 2012, 28:i640-i646
-
(2012)
Bioinformatics
, vol.28
, pp. i640-i646
-
-
Ng, S.1
Collisson, E.A.2
Sokolov, A.3
Goldstein, T.4
Gonzalez-Perez, A.5
Lopez-Bigas, N.6
Benz, C.7
Haussler, D.8
Stuart, J.M.9
-
58
-
-
77954195272
-
Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM
-
Vaske CJ, Benz SC, Sanborn JZ, Earl D, Szeto C, Zhu J, Haussler D, Stuart JM: Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM. Bioinformatics 2010, 26:i237-245
-
(2010)
Bioinformatics
, vol.26
, pp. i237-245
-
-
Vaske, C.J.1
Benz, S.C.2
Sanborn, J.Z.3
Earl, D.4
Szeto, C.5
Zhu, J.6
Haussler, D.7
Stuart, J.M.8
-
59
-
-
79955941549
-
Quantitative proteomic analysis in breast cancer
-
Tabchy A, Hennessy BT, Gonzalez-Angulo AM, Bernstam FM, Lu Y, Mills GB: Quantitative proteomic analysis in breast cancer. Drugs Today (Barc) 2011, 47:169-182
-
(2011)
Drugs Today (Barc)
, vol.47
, pp. 169-182
-
-
Tabchy, A.1
Hennessy, B.T.2
Gonzalez-Angulo, A.M.3
Bernstam, F.M.4
Lu, Y.5
Mills, G.B.6
-
60
-
-
84885647278
-
Connecting genomic alterations to cancer biology with proteomics: the NCI Clinical Proteomic Tumor Analysis Consortium
-
Ellis MJ, Gillette M, Carr SA, Paulovich AG, Smith RD, Rodland KK, Townsend RR, Kinsinger C, Mesri M, Rodriguez H, Liebler DC, Clinical Proteomic Tumor Analysis Consortium (CPTAC): Connecting genomic alterations to cancer biology with proteomics: the NCI Clinical Proteomic Tumor Analysis Consortium. Cancer Discov 2013, 3:1108-1112
-
(2013)
Cancer Discov
, vol.3
, pp. 1108-1112
-
-
Ellis, M.J.1
Gillette, M.2
Carr, S.A.3
Paulovich, A.G.4
Smith, R.D.5
Rodland, K.K.6
Townsend, R.R.7
Kinsinger, C.8
Mesri, M.9
Rodriguez, H.10
Liebler, D.C.11
|